Evidence map›Paper›PMID 42275142›Full record

ArticleKidney3602026

Cross-Species Comparison between Mouse Kidney Multi-Omics and Human Genome-Wide Association Studies Highlights Molecular Features Associated with Oxalate Nephropathy.

Ryosuke Chaya, Kazumi Taguchi, Yutaka Hashimoto, Yuya Shirai, Ryuya Edahiro, Noah Sasa, Kenichi Yamamoto, Yoshihiro Tomofuji, Shinichi Namba, Kyuto Sonehara and 8 more

Abstract readComparative Study
In one paragraph

Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ryosuke ChayaDepartment of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID 0009-0001-9351-8305
Kazumi TaguchiDepartment of Urology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-3092-5114
Yutaka HashimotoDepartment of Cell Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID 0000-0002-1380-7597
Yuya ShiraiDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.
Ryuya EdahiroDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0001-5009-6408
Noah SasaDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0009-0008-1517-6259
Kenichi YamamotoDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0001-9594-7050
Yoshihiro TomofujiDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-1661-0941
Shinichi NambaDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-7486-3146
Kyuto SoneharaDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-4536-1761
Rei UnnoDepartment of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID 0000-0003-0584-3712
Shuzo HamamotoDepartment of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID 0000-0002-9968-7468
Atsushi OkadaDepartment of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID 0000-0003-2080-3794
John MuroskiDepartment of Molecular Biology, Princeton University, Lewis Thomas Laboratory, Washington Road, Princeton, New Jersey.ORCID 0000-0002-0838-6767
Yoichi KatoDepartment of Cell Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID 0000-0002-2206-7279
Ileana M CristeaDepartment of Molecular Biology, Princeton University, Lewis Thomas Laboratory, Washington Road, Princeton, New Jersey.ORCID 0000-0002-6533-2458
Yukinori OkadaDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.
Takahiro YasuiDepartment of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID 0000-0003-2197-2477

Funding

Grant-in-Aid for Research in Nagoya City University 2313031
6 · The paper itself

Abstract

key pointsThe cross-species integration of mouse kidney multi-omics and human genome-wide association study identified 46 cross-species urolithiasis-related molecules. Cell type enrichment suggested that immune cells and collecting duct principal cells may play roles in urolithiasis pathophysiology. Follow-up analyses using human renal data, colocalization, and Mendelian randomization supported the relevance of the detected 46 molecules in humans.

backgroundUrolithiasis, a recurrent and increasingly prevalent disease worldwide, has a complex pathophysiology that hinders a comprehensive understanding.

methodsWe performed a cross-species integrative analysis combining multi-omics profiling of kidneys from a hyperoxaluric mouse model and summary statistics from a large-scale human genome-wide association study (GWAS).

resultsIn the multi-omics analysis of kidneys from a hyperoxaluric mouse model using RNA-seq, whole-cell proteomics, and phosphoproteomics, we identified 1173 genes, 342 proteins, and 516 phosphorylated peptides that were differentially expressed compared with control mice. We used publicly available large-scale meta-GWAS summary statistics of urolithiasis from BioBank Japan, UK Biobank, and FinnGen ( n =198,769) and prioritized genes using gene enrichment analysis. Through cross-species integration of mouse and human omics, we identified 46 molecules potentially relevant to urolithiasis, hereafter referred to as cross-species urolithiasis-related molecules. We examined the expression and genetic associations of these 46 molecules in human urolithiasis. Among these, CRYAB and SHROOM3 showed differential expression in human renal papilla tissues with and without stones. Colocalization analysis between urolithiasis GWAS and expression quantitative trait loci data of human renal tubules and glomeruli suggested shared signals at the GLUD1 , UMOD , SLC34A1 , TCEA3 , and H1-0 regions. Mendelian randomization analysis using the same renal expression quantitative trait loci datasets further supported these findings, with GLUD1 , UMOD , TCEA3 , and H1-0 showing statistically significant associations, suggesting a strong genetic link with urolithiasis.

conclusionsThe study's findings highlight a set of cross-species urolithiasis-related molecules, supported by both expression and genetic evidence, offering insights for future functional validation and mechanistic investigations.

Indexed as

HyperoxaluriaKidneyUrolithiasisAnimalsDisease Models, AnimalGenome-Wide Association StudyHumansMaleMiceMultiomicsProteomicsSpecies SpecificityUromodulinUMOD protein, humanUmod protein, mouseUromodulingene expressionhuman geneticskidney stonesproteomics

Identifiers

PMID42275142
PMCPMC13641535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.